Singapore-based well being expertise firm MiyaHealth has acquired an undisclosed sum of funding from HealthXCapital, Central Capital Ventura, and SEEDS Capital.
This comes on high of the $4.8 million it raised in a pre-Sequence A spherical earlier this 12 months.
Based in 2019, the startup affords two expertise platforms: MiyaPatient, a navigation platform that helps sufferers handle their power sickness, and MiyaPayor, which mixes AI-powered claims processing and predictive analytics. It’s developing with a 3rd providing, MiyaProvider, which is meant to reinforce sufferers’ expertise in hospitals and clinics.
At current, over 3,000 medical suppliers and 12,000 physicians have been utilizing these platforms.
WHAT IT’S FOR
The corporate mentioned the extra funding will assist enhance its product improvement, hiring, and enlargement plans. Particularly, it can help in its efforts to deploy MiyaPatient for the primary time in Europe and the MiyaPayor and MiyaProvider platforms in Indonesia and the Philippines.
THE LARGER TREND
Alongside this announcement, MiyaHealth additionally disclosed that it’s making ready to launch a Sequence A fundraiser “within the subsequent six months,” the proceeds of which can assist “additional develop its product suite, increase its operations globally, and proceed embarking on collaborations with key stakeholders shifting ahead”.
Asia’s consumer-centric digital well being ecosystem continues to develop with rising demand. It has been projected that the area’s digital well being market might attain $100 billion in worth by 2025 from $37 billion in 2020, primarily based on a report by McKinsey & Co.